Not yet recruiting

A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19) (BLAZE-5)

J2X-MC-PYAJ - ClinicalTrials.gov - NCT04701658

The purpose of this study is to find out whether bamlanivimab is able to stop COVID-19 from getting worse.
How long will I be in the trial?
Your participation could last about 3 months and may include up to 2 visits to the study center.
Email
Not yet recruiting

A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19) (BLAZE-5)

J2X-MC-PYAJ - ClinicalTrials.gov - NCT04701658

The purpose of this study is to find out whether bamlanivimab is able to stop COVID-19 from getting worse.
How long will I be in the trial?
Your participation could last about 3 months and may include up to 2 visits to the study center.
Email

Key Requirements

Age :

12+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

12+

Sex

All

Participants must

Participants must have mild to moderate symptoms of COVID-19

Participants must test positive for COVID-19 within 10 days of first symptom(s)

Participants must be at high risk for progressing to severe COVID-19 and/or needing hospitalization

Participants must NOT

Participants must not be in the hospital

Participants must not be very overweight

Participants must not need a machine to help them breathe (ventilator)

Participants must not have a serious medical condition or infection other than COVID-19

Participants must not have received SARS-CoV-2 vaccine or plasma from a patient who has recovered from COVID-19 (convalescent plasma)

Participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

COVID-19 (Coronavirus)

What the trial is testing?

Bamlanivimab

Could I receive a Placebo?

no

Enrollment Goal

3000

Trial Dates

January 2021 - August 2021

Trial Phase

2

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

12+

Sex

All

Participants must

Participants must have mild to moderate symptoms of COVID-19

Participants must test positive for COVID-19 within 10 days of first symptom(s)

Participants must be at high risk for progressing to severe COVID-19 and/or needing hospitalization

Participants must NOT

Participants must not be in the hospital

Participants must not be very overweight

Participants must not need a machine to help them breathe (ventilator)

Participants must not have a serious medical condition or infection other than COVID-19

Participants must not have received SARS-CoV-2 vaccine or plasma from a patient who has recovered from COVID-19 (convalescent plasma)

Participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

COVID-19 (Coronavirus)

What the trial is testing?

Bamlanivimab

Could I receive a Placebo?

no

Enrollment Goal

3000

Trial Dates

January 2021 - August 2021

Trial Phase

2

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

COVID-19 (Coronavirus) Resources

COVID-19

Lilly's COVID-19 Clinical Trials are Underway

Lilly has worked quickly to launch studies of potential COVID-19 antibody treatments. Find out what makes antibodies an intriguing scientific and medical option.
COVID-19

Types of Clinical Research for COVID-19

As the world works to quickly learn about COVID-19, a mix of research studies is underway. This guide explains the different types of COVID-19 studies and what researchers hope to learn from them.
COVID-19 teams chat

COVID-19 Research

COVID-19 is caused by SARS-CoV-2, a novel coronavirus. Because it is a relatively new disease, scientists and physicians do not know much about it, and currently, there are not many medicines to treat it. That’s why we need clinical research—to test potential new treatments for COVID-19. Read on to see if a clinical trial may be right for you.
Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?